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Introduction
Tobacco kills nearly 6 million people per year 
on account of direct tobacco use or indirect 
smoke exposure [World Health Organization 
(WHO) 2014]. Cigarette smoking, the 
primary method of tobacco consumption, is a 
major cause of preventable diseases (including 
cardiovascular diseases, respiratory diseases, 
and cancers) (Cunningham et al. 2014; Rea 
et al. 2002; Sosnowski and Przewoźniak 
2015) and mortality (Ezzati and Lopez 2003; 
Mathers and Loncar 2006). Various human 
carcinogens have been identified in cigarette 
smoke, including polycyclic aromatic hydro-
carbons (PAHs) [International Agency for 
Research on Cancer (IARC) 2004; Centers 
for Disease Control and Prevention (CDC) 
2010; Rodgman et al. 2000]. Although 
the adverse health effects of smoking are 
well acknowledged, less is known about its 
underlying mechanisms of toxicity, especially 
at the molecular level.
DNA methylation is an epigenetic modifi-
cation of the genome that is involved in regu-
lating gene expression and genome stability 
(Lee and Pausova 2013). Methylation status 
can be modified by both genetic and envi-
ronmental factors, and it can integrate the 
effects of both gene and environment on a 
phenotype or disease (Feil and Fraga 2012; 
Schadt 2009). Previous studies using targeted 
approaches (global methylation and candidate 
gene methylation) have established potential 
links between smoking and DNA methyla-
tion (Furniss et al. 2008; Philibert et al. 2010; 
Smith et al. 2007), but it was not until the 
widespread use of genome-wide methylation 
technologies that hundreds of smoking-related 
methylation markers were discovered and their 
relationships with smoking-related diseases 
were evaluated (Besingi and Johansson 2014; 
Breitling et al. 2011; Elliott et al. 2014; Harlid 
et al. 2014; Joubert et al. 2012; Markunas 
et al. 2014; Shenker et al. 2013; Sun et al. 
2013; Zeilinger et al. 2013). Previous genome-
wide methylation analyses of smoking have 
been conducted in Europeans (Guida et al. 
2015; Shenker et al. 2013; Zeilinger et al. 
2013) and African Americans (Dogan et al. 
2014; Philibert et al. 2013; Sun et al. 2013); 
however, populations of mid-income coun-
tries such as China, the biggest cigarette 
producer and customer in the world, have not 
been evaluated.
To investigate epigenome-wide methyla-
tion alterations in relation to cigarette smoking 
in a Chinese population, we measured DNA 
methylation levels at > 485,000 CpG sites 
(CpGs) in peripheral blood leukocytes and 
conducted a genome-wide meta-analysis of 
DNA methylation and smoking in a total of 
596 Chinese participants. Furthermore, we 
investigated the correlations of smoking-
related CpGs with the expression of annotated 
genes as well as their associations with urinary 
monohydroxy-PAH (OH-PAH) metabolites.
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Background: Smoking is a risk factor for many human diseases. DNA methylation has 
been related to smoking, but genome-wide methylation data for smoking in Chinese 
 populations is limited.
oBjectives: We aimed to investigate epigenome-wide methylation in relation to smoking in a 
Chinese population.
Methods: We measured the methylation levels at > 485,000 CpG sites (CpGs) in DNA from 
leukocytes using a methylation array and conducted a genome-wide meta-analysis of DNA methyla-
tion and smoking in a total of 596 Chinese participants. We further evaluated the associations of 
smoking-related CpGs with internal polycyclic aromatic hydrocarbon (PAH) biomarkers and their 
correlations with the expression of corresponding genes.
results: We identified 318 CpGs whose methylation levels were associated with smoking at a 
genome-wide significance level (false discovery rate < 0.05), among which 161 CpGs annotated to 
123 genes were not associated with smoking in recent studies of Europeans and African Americans. 
Of these smoking-related CpGs, methylation levels at 80 CpGs showed significant correlations with 
the expression of corresponding genes (including RUNX3, IL6R, PTAFR, ANKRD11, CEP135 
and CDH23), and methylation at 15 CpGs was significantly associated with urinary 2-hydroxy-
naphthalene, the most representative internal monohydroxy-PAH biomarker for smoking.
conclusion: We identified DNA methylation markers associated with smoking in a Chinese 
population, including some markers that were also correlated with gene expression. Exposure to 
naphthalene, a byproduct of tobacco smoke, may contribute to smoking-related methylation.
citation: Zhu X, Li J, Deng S, Yu K, Liu X, Deng Q, Sun H, Zhang X, He M, Guo H, Chen W, 
Yuan J, Zhang B, Kuang D, He X, Bai Y, Han X, Liu B, Li X, Yang L, Jiang H, Zhang Y, Hu J, 
Cheng L, Luo X, Mei W, Zhou Z, Sun S, Zhang L, Liu C, Guo Y, Zhang Z, Hu FB, Liang L, 
Wu T. 2016. Genome-wide analysis of DNA methylation and cigarette smoking in a Chinese 
population. Environ Health Perspect 124:966–973; http://dx.doi.org/10.1289/ehp.1509834
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Methods
Study Participants
In the present study, the genome-wide meta-
analysis of DNA methyla tion and smoking 
was conducted in 596 Chinese participants 
selected from the Coke Oven Cohort, acute 
coronary syndrome (ACS) patients from 
Wuhan and Guangdong, China, and the 
Wuhan-Zhuhai (WHZH) Cohort (see Figure 
S1, for a flowchart of the study).
The Coke Oven Cohort. A total of 1,628 
coke-oven workers (COW) were recruited 
from a coke-oven plant in Wuhan, China 
in 2010 (Li et al. 2012). We included 144 
workers in the present study based on the 
following criteria: a) donated blood and 
urine samples; b) had baseline total urinary 
OH-PAH (ΣOH-PAH) levels in the high 
tertile; c) had worked in the plant for more 
than 5 years; d) had no self-reported diseases or 
discomfort; e) had no fever or infectious condi-
tions within 2 weeks of the baseline examina-
tion; f) did not take prescribed medicine in 
the past month; and g) had a body mass index 
(BMI) of 18.0–30.5. After quality controls 
for methyla tion and genotyping data were 
performed, 137 individuals (abbreviated as 
COW-1) remained in the present study.
Acute coronary syndrome patients. The 
present study also included 103 clinically 
confirmed acute coronary syndrome (ACS) 
patients from Wuhan, China (recruited in 
Union Hospital and Wuhan Central Hospital), 
and 103 ACS patients from Guangdong, China 
(recruited in Bao’an Hospital and Peoples’ 
Hospital of Zhuhai). Patients were a) diag-
nosed with acute myocardial infarction or 
unstable angina pectoris by professional clini-
cians; b) did not have complications including 
congenital heart disease, cardiomyopathy, 
autoimmune disease, acute infection, tubercu-
losis, chronic obstructive pulmonary disease, 
diabetes mellitus, severe kidney or liver disease, 
hyperthyroidism, or malignant neoplasms; 
and c) donated blood samples at the earliest 
convenient time on the first day of admis-
sion. We included 101 patients from Wuhan 
(abbreviated as ACS-1) and 97 patients from 
Guangdong (abbreviated as ACS-2) who passed 
quality controls for both methylation data and 
genotyping data in the present analysis.
The Wuhan–Zhuhai (WHZH) Cohort. 
The WHZH Cohort is a community-based 
cohort established in 2011 with 4,812 indi-
viduals (3,053 from Wuhan and 1,759 from 
Zhuhai, respectively) recruited at baseline 
(Song et al. 2014). From all participants 
who a) had no acute or chronic diseases or 
any kind of discomfort; b) showed no sign 
of abnormalities in clinical exanimations; 
c) had no fever or infectious conditions 
within 2 weeks of the baseline examination; 
d) did not take prescribed medicine in the 
past month; and e) donated both blood and 
urine samples, a total of 180 Wuhan residents 
were selected as healthy controls for the ACS 
patients in Wuhan (matched for age, sex, 
and BMI, n = 103) and/or healthy and low–
PAH-exposed controls for COWs in Wuhan 
(matched for age, sex, and BMI, and with 
urinary ΣOH-PAH in the low tertile, n = 144; 
ACS patients and COWs shared 64 controls). 
A total of 103 Guangdong residents were 
selected as healthy controls for ACS patients 
from Guangdong (matched for age, sex, and 
BMI). We included 162 Wuhan residents 
and 99 Guangdong residents (abbreviated 
as WHZH) who passed quality controls for 
both methylation and genotyping data in the 
present analysis.
Subjects for investigating methylation-
expression correlations. To investigate the 
correlation between DNA methylation and 
gene expression, we recruited 144 individuals 
who participated in regular health examina-
tions at the Health Examination Center of 
Dongfeng Central Hospital (Dongfeng 
Motor Corporation and Hubei University of 
Medicine) in Shiyan, China during April and 
May of 2015. The selected participants met 
the following criteria: a) were 20 to 70 years 
of age; b) had no self-reported diseases or 
discomfort; c) had no fever or infectious 
conditions within 2 weeks of the baseline 
examination; d) took no prescribed medicine 
in the past month; and e) donated both blood 
and urine samples. The methylation and 
expression data for all 144 subjects (abbrevi-
ated as SY) passed quality control and were 
included in the present analysis.
Our study was approved by the Ethics 
Committee of Tongji Medical College, and 
written informed consent was obtained from 
each participant. We required all participants 
to consume a bland diet and to fast for at 
least 12 hr before donating blood samples. 
Biological samples from all study panels were 
collected according to the same protocol and 
were stored under similar conditions.
Laboratory Assays
Illumina HumanMethylation450 BeadChip. 
Genomic DNA was extracted from whole 
blood using a BioTeke Whole Blood DNA 
Extraction Kit (BioTeke) and was then stored 
at –80°C. One microgram of each sample was 
bisulfite converted using a Zymo EZ DNA 
Methylation kit (Zymo Research) according 
to the manufacturer’s instructions and was 
then diluted to a concentration of 60 ng/μL. 
DNA methylation was assayed at > 485,000 
CpGs using a HumanMethylation450 
BeadChip (Illumina) with 4-μL bisulfite-
converted samples.
HumanHT-12 v4 Expression BeadChip. 
Leukocytes were isolated from whole blood 
immediately after blood collection, and the 
total RNA of blood leukocytes was isolated 
using TRIzol® LS solution (Invitrogen) 
according to the manufacturer’s instructions. 
Gene expression was profiled by a commer-
cial company (ETMD, Beijing, China) using 
a HumanHT-12 v4 Expression BeadChip 
array according to standard protocols from 
Illumina. We acquired raw expression values 
using GenomeStudio (Illumina) and normal-
ized the expression data using quantile-
quantile normalization with the “beadarray” 
package (Dunning et al. 2007) in R 3.1.2 (R 
Core Team 2014). All unexpressed signals 
were assigned as 0 before analysis.
Urinary creatinine and OH-PAH meas-
urement. The urinary measures of creatinine 
and 12 OH-PAH metabolites in the WHZH 
(Song et al. 2014) and COW (Deng et al. 
2014; Li et al. 2012) cohorts have been 
previously reported. All urine samples were 
collected in sterile conical tubes and were 
stored at –20°C until the laboratory assays 
were performed. The identification and quan-
tification of PAH metabolites were based on 
retention time, mass-to-charge ratio, and peak 
area using a linear regression curve obtained 
from separate internal standard solutions. 
Among the 12 urinary OH-PAH metabolites, 
10 noncarcinogenic metabolites, including 
1-hydroxynaphthalene, 2-hydroxynaphtha-




and 1-hydroxypyrene were above the limits 
of quantification (LOQ) and were hence 
included in the present analysis, whereas the 2 
carcinogenic metabolites, 6-hydroxy chrysene 
and 3-hydroxy benzo[a]pyrene, were below 
the LOQ (Deng et al. 2014; Li et al. 2012) 
and, therefore, were not used in the present 
analysis. The OH-PAH levels were calibrated 
to urinary creatinine and were presented as 
micromoles per millimole creatinine.
Quality Controls for Genome-Wide 
Data 
We randomized sample pairs of cases (disease 
or exposed group) and matched controls 
across different plates and beadchips to 
minimize batch effects. We used the minfi 
package (Aryee et al. 2014) to preprocess 
the IDAT files. Signal outliers were identi-
fied by multidimensional scaling (MDS) 
analysis. We examined potential sample 
mix-ups by matching genotypes of the 65 
single nucleotide polymorphisms (SNPs) on 
the Methylation450k Beadchips with the 
genotypes of the same SNPs obtained from 
the genome-wide association study (GWAS) 
data. Methylation probes were excluded if 
they: a) were the 65-SNP probes; b) had a 
missing rate > 20% across samples (missing 
was defined as follows for a probe of a 
Zhu et al.
968 volume 124 | number 7 | July 2016 • Environmental Health Perspectives
certain sample: detection p value > 0.01 or 
bead counts < 3); or c) potentially contained 
or extended on SNPs with MAF > 0.05 in 
the 1000 Genomes Project 20110521 release 
for the ASN population, or cross-hybridized 
to other genomic locations (41,296 probes). 
Samples were excluded if they a) were MDS 
outliers; b) were mix-up samples; c) had a 
missing rate > 0.05 across probes; or d) failed 
GWAS quality controls, including unexpected 
duplicates or relatives (in IBD analysis, PI_
HAT>0.185), sex discrepancies, heterozygosity 
outliers, or individual call rate < 0.98. After 
filtering, methylation values at 431,369 CpGs 
were normalized using the dasen method in 
the wateRmelon package (Pidsley et al. 2013). 
Methylation values with detection p value 
> 0.01 or bead counts < 3 were assigned as NA 
before further analysis.
Statistical Analysis
Genome-wide analyses of DNA methylation 
and smoking. Partici pants who had smoked an 
average of > 1 cigarette/day over the previous 
6 months were defined as current smokers; 
participants who had stopped smoking for 
> 6 months were defined as former smokers; 
and participants who had never smoked during 
their lifetimes were classified as never smokers. 
Individuals who drank alcohol > 1 time/
week over the previous 6 months were 
defined as current drinkers; individuals who 
had stopped drinking for > 6 months were 
defined as former drinkers; and individuals 
who had never had alcohol were defined as 
never drinkers. Surrogate variable analysis 
(SVA) was conducted separately in each panel 
using the SVA package (Leek et al. 2012). 
Variables used in the SVA included smoking 
status (coded as 0, 1, and 2 for never, former, 
and current smokers, respectively), age (years, 
as a continuous variable), sex (coded as 1 and 
2 for male and female, respectively), drinking 
status (coded as 0, 1, and 2 for never, former, 
and current drinkers, respectively), and BMI 
(kilograms per meters squared, as a continuous 
variable). Surrogate variables (SVs) can capture 
major unknown variations of the genome-wide 
data that cannot be explained by included 
variables. Association analyses were performed 
separately in each panel using linear regres-
sion models, with inverse-normal transformed 
(INT) methylation beta values included as 
dependent variables and smoking status, age, 
sex, drinking status, BMI, and SVs included 
as independent variables. In the analyses of 
the COW and WHZH cohorts, ΣOH-PAHs 
were also included in the models as covari-
ates because ΣOH-PAHs were considered in 
sample selection in these two panels. Results 
from all four panels were combined using a 
fixed effect meta-analysis with a sample-size 
weighted method to obtain p values and an 
inverse-variance weighted method to obtain 
estimates of effect size. The significance 
threshold for the genome-wide meta-analysis 
was a false discovery rate (FDR) < 0.05. The 
analyses were performed in R 3.1.2 (R Core 
Team 2014).
Correlation between CpGs and gene 
expression. CpGs and expression probes were 
paired based on annotation files provided by 
Illumina, which provided information on 
genomic locations and gene annotations for 
both expression probes and CpGs probes. 
Linear regressions, of which dependent 
variables were inverse-normal–transformed 
expression values and independent vari-
ables were methylation values, age, and sex, 
were used to estimate associations between 
methyla tion and expression. For each CpG, 
the significance threshold was defined as 
0.05/number of expression probes of the 
corresponding gene.
Urinary PAH metabolites and smoking-
related methylation alterations. We evaluated 
which urinary OH-PAHs could be used as 
representative biomarkers of smoking exposure 
by calculating the contribution of smoking 
to each OH-PAH metabolite [defined as the 
difference of R2 between the models with 
and without smoking status; other covariates 
were age, drinking status, BMI, occupation, 
geographical region and beadchip operation 
date (geographical regions were coded as 1 and 
2 for Wuhan and Guangdong, respectively)] 
using linear regression models in males from 
the WHZH cohort. The association between 
methylation values of the smoking-related 
CpGs and urinary 2-hydroxynaphthalene 
levels were analyzed seperately in males from 
the WHZH cohort and the Coke Oven 
cohort. Mediation analysis was performed 
to evaluate whether 2-hydroxynaphthalene 
showed mediation effects of smoking on meth-
ylation alterations in males from the WHZH 
cohort with adjustment for age, drinking 
status, BMI, occupation, differential leukocyte 
proportion, geographical region and beadchip 
operation date (Valeri and Vanderweele 2013). 
The association analyses were conducted in R 
3.1.2 (R Core Team 2014), and the media-
tion analyses were performed in SAS 9.2 (SAS 
Institute Inc.).
Results
Basic Characteristics of the 
Participants
The genome-wide meta-analysis contained 
a total of 596 participants recruited from 
China, including 137 coke-oven workers 
(107 males; mean age = 46.51 years), 198 
ACS patients (including 101 from Wuhan 
with 81 males and a mean age of 58.96 years, 
and 97 from Guangdong with 78 males and 
a mean age of 59.37 years), and 261 commu-
nity residents from the WHZH cohort 
(206 males, mean age = 53.84 years). The 
characteristics of the study populations are 
 summarized in Table 1.
Genome-Wide Analysis of DNA 
Methylation and Smoking
In our genome-wide methylation meta-
analysis, we identified 318 CpGs whose 
methylation levels were associated with 
smoking at genome-wide significance level 
(FDR < 0.05, Figure 1). Of these, 161 CpGs 
annotated to 123 genes were not reported to 
be significantly associated with smoking in 
previous genome-wide studies of methyla-
tion and smoking in Europeans (Guida et al. 
2015; Shenker et al. 2013; Zeilinger et al. 
Table 1. Characteristics of the study participants (n or mean ± SD).
Characteristics
Genome-wide meta-analysis of DNA methylation and smoking
Data set for methylation-
expression association analysis
COW-1 (n = 137) ACS-1 (n = 101) ACS-2 (n = 97) WHZH (n = 261) SY (n = 144)
Age, years 46.51 ± 8.91 58.96 ± 10.20 59.37 ± 11.47 53.84 ± 13.06 41.31 ± 10.27
Male, n (%) 107 (78.1%) 81 (80.2%) 78 (80.4%) 206 (78.9%) 107 (74.3%)
Smoking status, current/former/non 84/3/50 40/23/38 40/13/44 109/25/127 45/2/97
Drinking status, current/former/non 49/4/84 23/0/78 20/0/77 81/5/175 55/1/88
Body mass index, kg/m2 23.47 ± 2.72 24.84 ± 2.80 22.97 ± 2.43 23.37 ± 2.76 24.22 ± 2.67
White blood count, 109/L 6.71 ± 1.51 7.31 ± 2.44 10.52 ± 3.82 6.00 ± 1.57 5.97 ± 1.40
Neutrophil proportions, % 59.62 ± 7.26 63.38 ± 10.50 72.50 ± 13.04 55.83 ± 8.33 57.97 ± 8.18
Lymphocyte proportions, % 36.83 ± 7.11 27.63 ± 9.73 19.07 ± 11.46 37.38 ± 8.17 33.68 ± 7.52
Intermediate cella proportions, % 3.55 ± 1.16 8.97 ± 3.08 8.44 ± 4.07 6.85 ± 3.75 8.35 ± 2.71
Abbreviations: ACS-1, ACS patients from Wuhan; ACS-2, ACS patients from Guangdong; COW-1, participants from the Coke Oven cohort; SY, individuals who attended regular health 
examinations in Shiyan; WHZH, residents selected from the Wuhan–Zhuhai cohort. 
aIntermediate cells were defined as the sum of monocytes, eosinophils, and basophils.
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2013) or in African Americans (Dogan et al. 
2014; Philibert et al. 2013; Sun et al. 2013) 
(see Table S1). The association results for the 
top 40 smoking-related CpGs (FDR < 0.01) 
are presented in Table 2, and the association 
results of the 318 smoking-related CpGs 
in each panel are presented in Table S2. 
For most of the 318 CpGs, we observed a 
gradational alteration trend of the methyla-
tion levels from never to former to current 
smokers; the methylation alterations from 
current smokers to nonsmokers were larger 
than the alterations from former smokers to 
nonsmokers (see Table S3).
Correlations with the Expression 
of Annotated Genes
We further investigated whether the meth-
ylation values of the smoking-related CpGs 
were correlated with the expression of corre-
sponding genes in an independent set of 144 
healthy individuals whose methylome and 
gene-expression profiles were both measured 
(Table 1). Seventy-seven of the 318 smoking-
related CpGs were excluded from the 
analysis either because no expression probes 
were designed for the genes or because of 
the low expression rate in blood leukocytes. 
Of the remaining 241 CpGs (a total of 414 
CpG-expression probe pairs) that had qualified 
expression data for the annotated genes, we 
observed that methylation levels at 80 CpGs 
were associated with the expression of their 
corresponding genes (p < 0.05/number of 
expression probes of the corresponding gene; 
e.g., on the body of RUNX3, p = 1.57 × 10–7 
for cg10951873 and ILMN_1787461; on the 
body of IL6R, p = 1.98 × 10–9 for cg09257526 
and ILMN_1696394, p = 5.61 × 10–6 
for cg09257526 and ILMN_1754753; 
within 1,500 bps from the transcription 
start site of CEP135, p = 1.82 × 10–2 for 
cg26542660 and ILMN_1693766; on 
the body of CDH23, p = 9.45 × 10–3 for 
cg10750182 and ILMN_1779934; within 
1,500 bps from the transcription start site of 
PTAFR, p = 2.07 × 10–16 for cg20460771 
and ILMN_1746836; in the 5´ untrans-
lated regions of ANKRD11, p = 1.03 × 10–8 
for cg01107178 and ILMN_2108709) 
(see Table S4).
Associations of Smoking-Related 
CpGs and Urinary 
2-Hydroxynaphthalene
Because the majority of smokers in our 
study were males (98.52%) and to avoid 
effects owing to occupational exposures, the 
analysis was mainly conducted in males from 
the WHZH cohort. We first tested which 
OH-PAH metabolite was the most represen-
tative biomarker for smoking. We observed 
that smoking could account for 18.0% of the 
variation of urinary 2-hydroxynaphthalene, 
larger than the variations explained by 
smoking for the other 9 OH-PAH  metabolites 
(see Table S5).
We then assessed the association between 
methylation levels at the 318 smoking-
related CpGs and urinary 2-hydroxynaph-
thalene levels (see Table S6) and found 15 
significant associations after performing 
Bonferroni corrections (p < 1.57 × 10–4) 
(Figure 2). When restricting the analysis only 
to nonsmokers, these associations were greatly 
attenuated (Figure 2; see also Table S6), 
suggesting that the correlations between 
DNA methylation and urinary 2-hydroxy-
naphthalene were mainly attributable to 
smoking. We further investigated whether 
2-hydroxynaphthalene could be a mediator 
of these smoking-induced methylation altera-
tions and found that among the 15 CpGs 
associated with 2-hydroxynaphthalene, the 
smoking-related methylation variation at 12 
CpGs (including cg05575921, cg23916896, 
cg24090911, and cg26703534 on AHRR) 
might be partially mediated by their asso-
ciations with urinary 2-hydroxynaphthalene 
levels (p < 0.05) (Table 3).
Although subjects from the Coke Oven 
cohort had occupational exposures to PAHs, 
similar association patterns between smoking, 
2-hydroxynaphthalene, and methylation at 
these CpGs were observed in male subjects 
from the Coke Oven cohort after adjust-
ment for 1-hydroxypyrene, an occupational 
exposure marker for coke-oven workers 
(Figure 2; see also Table S6).
Discussion
In the present study, we identified 318 
smoking-related CpGs through a genome-
wide meta-analysis of DNA methylation in 
several Chinese populations. Among the iden-
tified CpGs, 161 annotated to 123 genes were 
not associated with smoking in recent studies 
of Europeans (Guida et al. 2015; Shenker 
et al. 2013; Zeilinger et al. 2013) or African 
Americans (Dogan et al. 2014; Philibert et al. 
2013; Sun et al. 2013). We also observed that 
methylation levels at some smoking-related 
CpGs might affect the expression of corre-
sponding genes, and some smoking-related 
methylation alterations might be partly 
mediated by exposure to naphthalene.
Although China is the largest consumer 
and producer of tobacco in the world (Gu 
et al. 2009), genome-wide methylation studies 
of DNA methylation and smoking have not 
been conducted in Chinese populations. The 
present study identified 318 smoking-related 
Figure 1. Manhattan plot and Q-Q plot of the p values of the associations between methylation and 
cigarette smoking in the genome-wide meta-analysis. In the Manhattan plot, the x-axis indicates genomic 
locations of the CpGs, the y-axis indicates –log10 (p-values) of the associations, and the red line indicates 
the –log (p-value) at false discovery rate (FDR) = 0.05. In the Q-Q plot, the x-axis shows the expected 
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CpGs in a Chinese population, 157 of which 
have been reported by previous methyla-
tion studies, suggesting that smoking-related 
methylation alterations were mainly consis-
tent across Chinese and Western populations. 
The 161 CpGs that have not been previously 
reported in Europeans or African Americans 
suggest novel smoking-related sites or sites 
specific to the Chinese population, which 
calls for replication by further studies among 
other Chinese populations. Most of the identi-
fied loci were annotated on genes involved in 
the metabolism of smoking-released chemi-
cals [e.g., AHRR is a repressor of the nuclear 
receptor for aryl hydrocarbons that is involved 
in xenobiotic metabolism (Shenker et al. 
2013)] or that might be involved in smoking-
related health effects [e.g., methylation of 
F2RL3 mediates the detrimental impacts of 
smoking and is related to mortality caused by 
coronary heart disease (Breitling et al. 2012; 
Zhang et al. 2014)].
DNA methylation might be a potential 
link between smoking and human diseases. 
In the present study, the smoking-related 
methyla tion changes to RUNX3, IL6R, 
PTAFR, and ANKRD11 (cardiovascular-
related genes) and CEP135 and CDH23 
(cancer-related genes) corresponded to 
increased gene expression. RUNX3 encodes 
a member of the runt domain-containing 
family of transcription factors, which might 
have important functions in innate and 
adaptive immune cell types and might be 
associated with several inflammatory-related 
diseases (Lotem et al. 2015). Interleukin 6 
is a cytokine with vital roles in inflamma-
tory responses, and its dysregulation has 
been implicated in many health problems 
(Ferreira et al. 2013). PTAFR encodes a 
receptor for platelet-activating factor (PAF) 
that plays a significant role in proinflam-
matory processes (Ninio et al. 2004). In 
addition to their critical role in hemostasis 
and thrombosis, platelets are also involved 
in regulating inflammatory and immune 
responses (von Hundelshausen and Weber 
2007). ANKRD11 might be involved in 
apoptosis pathways (e.g., p53 signaling) 
(Lim et al. 2012; Neilsen et al. 2008), which 
have been reported to play key roles in the 
pathogenesis of cardiovascular diseases (Lee 
and Gustafsson 2009). It has been speculated 
that smoking-induced abnormal physiological 
processes might be important mechanisms in 
the development of cardiovascular diseases 
(Frostegård 2013). Our findings that 
smoking was associated with methylation 
of  cardiovascular- related genes that were 
correlated with the corresponding expres-
sion suggested that DNA methylation might 
contribute to disease progression though 
immune reactions, inflammation responses, 
and apoptosis induced by smoking.
CEP135 encodes a centrosomal protein 
that acts as a scaffolding protein during 
early centriole biogenesis (Kim et al. 2008). 
Centrosomes play crucial roles in many 
processes (including organizing mitotic 
spindle poles), and centrosome aberrations 
(Nigg 2002) are included in many human 
tumors (Rusan and Peifer 2007). Notably, 
antimitotic compounds have been identified 
in tobacco-smoke condensate, and smoking 
could induce mitotic abnormalities (Qiao 
et al. 2003; Vogt Isaksen 2004). CDH23 
encodes cadherin 23, which acts as a mediator 
at intercellular junctions and in cellular differ-
entiation and cell migration (Agarwal 2014). 
Previous studies showed that CDH23 was 
up-regulated in breast cancer tissues and was 
involved in metastatic processes (Binai et al. 
2013). Recent evidence has suggested that 
active smoking played a potentially causal 
role in breast cancer (Reynolds et al. 2009). 
Smoking is also a well-established cause of 
many cancers (e.g., lung, colon, and stomach) 
(Gandini et al. 2008). Therefore, it is possible 
that methylation alterations are potential 
mechanisms of smoking-induced adverse 
effects and cancers.
Cigarette smoking is a major source 
of PAH exposure, particularly naphtha-
lene exposure (Ding et al. 2005; Jacob et al. 
2013). We estimated that cigarette smoking 
accounted for 18.0% of the variation in 
urinary 2-hydroxynaphthalene among males 
in the WHZH cohort, which supports further 
investigation of urinary 2-hydroxynaphthalene 
as a possible biomarker of internal exposure 
to smoking-sourced PAHs. Smoking-related 
alterations of AHRR methylation might be 
caused by exposure to PAHs (Shenker et al. 
2013). AHRR encodes a repressor of the aryl 
Table 2. The 40 CpGs associated with cigarette smoking in the genome-wide meta-analysis (FDR < 0.01).
Chr Position Gene
Relation 
to gene CpG Effect (s.e.)a p FDR
1 11908164 NPPA TSS1500 cg05396397 0.257 (0.047) 1.02 × 10–7 6.97 × 10–4
1 19717337 CAPZB Body cg07573717 –0.104 (0.020) 1.00 × 10–7 6.97 × 10–4
1 21617442 ECE1 TSS1500 cg26348226 –0.143 (0.030) 2.18 × 10–6 0.007
1 42367407 HIVEP3 5’UTR cg14663208 0.193 (0.035) 1.63 × 10–7 9.99 × 10–4
1 154299179 ATP8B2 TSS1500 cg06811467 –0.126 (0.021) 1.29 × 10–8 1.22 × 10–4
1 154379696 IL6R Body cg09257526 –0.112 (0.020) 5.59 × 10–8 4.16 × 10–4
2 11969958 - cg02560388 –0.180 (0.037) 1.60 × 10–6 0.006
2 176987918 HOXD9 1stExon cg22674699 0.216 (0.043) 7.15 × 10–7 0.003
2 231790037 GPR55 TSS200 cg16382047 –0.128 (0.026) 1.31 × 10–6 0.005
3 99792561 C3orf26 Body cg15554421 –0.159 (0.031) 5.94 × 10–7 0.003
4 56813860 CEP135 TSS1500 cg26542660 –0.150 (0.026) 1.57 × 10–8 1.41 × 10–4
4 95679705 BMPR1B 5’UTR cg09156233 0.198 (0.042) 3.15 × 10–6 0.010
5 146614298 STK32A TSS1500 cg09088988 0.177 (0.035) 5.57 × 10–7 0.003
6 46702983 PLA2G7 1stExon cg18630040 0.196 (0.038) 6.68 × 10–7 0.003
7 1102177 C7orf50 Body cg15693483 –0.161 (0.027) 3.33 × 10–9 3.79 × 10–5
7 147065665 MIR548I4 Body cg15700587 0.181 (0.034) 1.81 × 10–7 0.001
7 158937969 VIPR2 TSS1500 cg23572908 0.239 (0.048) 1.16 × 10–6 0.004
9 127054428 NEK6 TSS1500 cg14556677 –0.111 (0.019) 7.99 × 10–9 8.02 × 10–5
10 49892930 WDFY4 TSS1500 cg15164194 –0.091 (0.020) 1.81 × 10–6 0.006
10 116298339 ABLIM1 Body cg07978738 –0.145 (0.028) 3.62 × 10–7 0.002
10 128994432 DOCK1 Body cg03242819 0.229 (0.044) 3.41 × 10–7 0.002
11 65201834 - cg10416861 0.216 (0.043) 8.67 × 10–7 0.004
11 65550444 - cg09419102 –0.141 (0.029) 1.60 × 10–6 0.006
11 122709551 CRTAM Body cg22512531 0.138 (0.026) 4.70 × 10–7 0.002
12 7055657 PTPN6 TSS200 cg23193870 –0.204 (0.042) 1.84 × 10–6 0.006
14 78051204 SPTLC2 Body cg14544289 –0.199 (0.041) 3.06 × 10–6 0.010
14 89933549 FOXN3 5’UTR cg13679772 0.149 (0.031) 1.94 × 10–6 0.007
14 106331803 - cg14387626 –0.142 (0.026) 4.34 × 10–8 3.47 × 10–4
14 106354912 - cg27113548 –0.284 (0.047) 4.60 × 10–9 5.09 × 10–5
15 99194021 IGF1R Body cg07779120 0.251 (0.046) 2.35 × 10–7 0.001
17 4923126 KIF1C Body cg03877174 0.154 (0.030) 7.12 × 10–7 0.003
17 9921982 GAS7 Body cg02018337 –0.122 (0.024) 4.43 × 10–7 0.002
17 27050723 RPL23A Body cg18150958 –0.229 (0.046) 8.85 × 10–7 0.004
17 27401793 TIAF1 5’UTR cg18960216 0.181 (0.034) 1.97 × 10–7 0.001
17 56082867 SFRS1 3’UTR cg08591265 –0.152 (0.032) 1.42 × 10–6 0.005
18 76739409 SALL3 TSS1500 cg05080154 0.212 (0.038) 4.87 × 10–8 3.75 × 10–4
19 40919465 PRX TSS200 cg01447828 0.233 (0.044) 1.54 × 10–7 9.63 × 10–4
19 53758055 ZNF677 5’UTR cg03217253 0.216 (0.042) 3.10 × 10–7 0.002
20 43438809 RIMS4 Body cg15207742 0.212 (0.043) 1.40 × 10–6 0.005
22 20792535 SCARF2 TSS1500 cg14785479 0.123 (0.025) 1.10 × 10–6 0.004
Abbreviations: Body, gene body; Chr, Chromosome; FDR, false discovery rate; TSS200, within 200 bps from transcription 
start site; TSS1500, within 1,500 bps from transcription start site; UTR, untranslated regions.
aEstimates were calculated based on inverse-normal transformed methylation values. Fixed effect meta-analysis was 
used with a sample size–weighted method to obtain p values and with an inverse-variance weighted method to obtain 
estimates of effect size.
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hydrocarbon receptor (AhR) (Harlid et al. 
2014). Previous studies have suggested that 
the AhR pathway is important in the metabo-
lism of various xenobiotics including PAHs 
(Zeilinger et al. 2013) and is modified in 
response to exposure to smoking (Besingi and 
Johansson 2014). Our present data suggested 
that smoking-released naphthalene might alter 
the AhR pathway by changing the methylation 
levels of vital genes in the AhR pathway.
Different cells and tissues have distinct 
DNA methylation signatures (Ohgane et al. 
2008). The use of peripheral blood DNA in 
the present study is reasonable for two reasons. 
First, peripheral blood is an important carrier 
for many xenobiotics absorbed into human 
bodies (Barr et al. 2007); peripheral blood cells 
have direct contact with the internal forms of 
xenobiotics and react to them (Bonassi et al. 
2007). Second, blood samples are the most 
convenient to collect in large-scale studies, and 
using blood cells allows comparison of our 
results with those of other studies. A limita-
tion of using blood leukocytes as the source 
of DNA for methylation analyses is that 
methylation varies among leukocyte subtypes, 
and the distribution of leukocyte subtypes 
may vary in association with exposure, thus 
resulting in potential confounding of asso-
ciations between exposures and methyla-
tion (Reinius et al. 2012). As suggested in a 
previous study that factor-based “batch” correc-
tion methodology (such as surrogate variable 
analysis) can not only control for batch effects 
but can also empirically estimate and control 
for cell-type compositions (Jaffe and Irizarry 
2014), we adopted surrogate variables in our 
genome-wide methylation analyses to limit 
effects of batch and cellular compositions 
simultaneously. When investigating asso-
ciations between smoking-related CpGs and 
urinary 2-hydroxynaphthalene, we adjusted 
for differential white blood cell proportions 
in the analysis models. However, we cannot 
rule out the potential for residual confounding 
related to leukocyte subtype variations or to 
other factors. In addition, given the cross-
sectional study design, we could not establish 
a temporal relationship between smoking and 
DNA methylation.
Table 3. Mediation analysis of 15 significant CpGs whose methylation levels were correlated with urinary 
2-hydroxynaphthalene in males from the Wuhan–Zhuhai (WHZH) cohort.
CpG Gene
Relationships between smoking, 2-hydroxynaphthalene, and methylation
 Total effect of smoking 
on methylationa
Mediating effect of 2-hydroxynaphthalene in 
association between smoking and methylationa
Total effect (s.e.) p Indirect effect (s.e.) p
cg05575921 AHRR –0.667 (0.060) 2.17 × 10–28 –0.084 (0.032) 0.008
cg21161138 AHRR –0.305 (0.074) < 1.00 × 10–05 –0.134 (0.041) 0.059
cg23916896 AHRR –0.085 (0.078) < 1.00 × 10–05 –0.136 (0.042) 0.017
cg23576855 AHRR –0.655 (0.059) <1.00 × 10–05 –0.056 (0.030) 0.100
cg24090911 AHRR –0.203 (0.074) 1.81 × 10–10 –0.124 (0.040) 0.009
cg25648203 AHRR –0.360 (0.071) < 1.00 × 10–05 –0.089 (0.037) 0.088
cg26703534 AHRR –0.428 (0.067) 1.10 × 10–17 –0.092 (0.035) 0.008
cg01940273 - –0.542 (0.063) < 1.00 × 10–05 –0.088 (0.033) 0.016
cg03636183 F2RL3 –0.464 (0.068) 3.70 × 10–05 –0.059 (0.034) 0.001
cg05284742 ITPK1 –0.273 (0.070) 0.273 –0.084 (0.036) 0.001
cg05951221 - –0.430 (0.068) 1.39 × 10–04 –0.057 (0.035) 0.015
cg09022230 TNRC18 –0.282 (0.073) 1.24 × 10–04 –0.103 (0.039) 0.008
cg09935388 GFI1 –0.274 (0.072) 0.006 –0.091 (0.037) 0.002
cg21322436 CNTNAP2 –0.284 (0.073) 9.90 × 10–05 –0.102 (0.038) 0.008
cg21566642 - –0.534 (0.067) 1.05 × 10–04 –0.083 (0.035) 0.021
aAdjusted for age, drinking status, body mass index, occupation, differential leukocyte proportions, geographical region, 
and beadchip operation date in a mediation macro in SAS 9.2 (SAS Institute Inc.): %macro mediation (data=, yvar=, 
avar=, mvar=, cvar=, a0=, a1=, m=, nc=, yreg=, mreg=, Interaction=, casecontrol= false, output= reduced, c=, boot=) 
(Valeri and Vanderweele 2013).
Methylation values were inverse-normal transformed, and concentrations of urinary 2-hydroxynaphthalene were 
natural log–transformed.
Figure 2. Associations of the 15 smoking-related CpGs and urinary 2-hydroxynaphthalene levels in males from the Wuhan–Zhuhai (WHZH) cohort and the Coke 
Oven cohort.
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Conclusions
On the basis of a genome-wide analysis of 
smoking and DNA methylation in a Chinese 
population, we identified 318 smoking-
related CpGs, among which 161 CpGs 
annotated to 123 genes have not been previ-
ously reported in Europeans or in African 
Americans. Some smoking-related CpGs 
might play a role in gene regulation. We 
also found that naphthalene might be one 
of the smoking-released chemicals inducing 
the methylation alterations that we observed 
in smokers. Additional studies are needed 
to replicate our findings, to determine their 
potential relevance to health outcomes, and 
to elucidate underlying mechanisms that link 
smoking and DNA methylation.
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